Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 34
1993 15
1994 26
1995 38
1996 54
1997 80
1998 90
1999 158
2000 175
2001 230
2002 246
2003 308
2004 288
2005 341
2006 346
2007 309
2008 316
2009 320
2010 347
2011 361
2012 424
2013 516
2014 497
2015 560
2016 555
2017 594
2018 591
2019 645
2020 739
2021 751
2022 784
2023 339

Text availability

Article attribute

Article type

Publication date

Search Results

10,013 results

Results by year

Filters applied: . Clear all
Page 1
Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial.
Messous S, Trabelsi I, Bel Haj Ali K, Abdelghani A, Ben Daya Y, Razgallah R, Grissa MH, Beltaief K, Mezgar Z, Belguith A, Bouida W, Boukef R, Boubaker H, Msolli MA, Sekma A, Nouira S. Messous S, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221099729. doi: 10.1177/17534666221099729. Ther Adv Respir Dis. 2022. PMID: 35657073 Free PMC article. Clinical Trial.
Typical administration periods range from 5 to 7 days. A 2-day course with levofloxacin was not previously assessed. We performed a randomized clinical trial to evaluate the efficacy of 2-day versus 7-day treatment with levofloxacin in patients with AECOPD. METHODS …
Typical administration periods range from 5 to 7 days. A 2-day course with levofloxacin was not previously assessed. We performed a r …
Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
Izadi M, Dadsetan B, Najafi Z, Jafari S, Mazaheri E, Dadras O, Heidari H, SeyedAlinaghi S, Voltarelli F. Izadi M, et al. Recent Pat Antiinfect Drug Discov. 2018;13(3):228-239. doi: 10.2174/1574891X13666181024154526. Recent Pat Antiinfect Drug Discov. 2018. PMID: 30360748 Clinical Trial.
Although standard regimen group (n=27, 36%) showed more consolidation than patients in Levofloxacin group (n=22, 29.3%), and the ground glass pattern was observed more in Levofloxacin group. CONCLUSION: We concluded that monotherapy with oral Levofloxacin was …
Although standard regimen group (n=27, 36%) showed more consolidation than patients in Levofloxacin group (n=22, 29.3%), and the grou …
A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infection.
Xue Z, Xiang Y, Li Y, Yang Q. Xue Z, et al. Ann Palliat Med. 2021 Sep;10(9):9765-9771. doi: 10.21037/apm-21-2042. Ann Palliat Med. 2021. PMID: 34628902 Free article.
BACKGROUND: The efficacy of levofloxacin and ciprofloxacin in the treatment of urinary tract infection is not clear yet. ...All the retrieved literatures were randomized comparative studies of levofloxacin and ciprofloxacin. The included studies were screened accord …
BACKGROUND: The efficacy of levofloxacin and ciprofloxacin in the treatment of urinary tract infection is not clear yet. ...All the r …
The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
Dai FF, Liu FQ, Chen X, Yang J, Wang K, Guo CY. Dai FF, et al. J Clin Pharm Ther. 2021 Jun;46(3):705-710. doi: 10.1111/jcpt.13331. Epub 2021 Jan 6. J Clin Pharm Ther. 2021. PMID: 33403672
This study aimed to evaluate the efficacy and safety of levofloxacin in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. ...This study will provide a reference for evaluating the efficacy and safety of levofloxacin in the paediatric population....
This study aimed to evaluate the efficacy and safety of levofloxacin in children with macrolide-resistant Mycoplasma pneumoniae pneum …
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Deshpande D, Pasipanodya JG, Mpagama SG, Bendet P, Srivastava S, Koeuth T, Lee PS, Bhavnani SM, Ambrose PG, Thwaites G, Heysell SK, Gumbo T. Deshpande D, et al. Clin Infect Dis. 2018 Nov 28;67(suppl_3):S293-S302. doi: 10.1093/cid/ciy611. Clin Infect Dis. 2018. PMID: 30496461 Free PMC article.
BACKGROUND: Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown. ...CONCLUSIONS: The levofloxacin dose of 25 mg/kg or 1500 mg/day was adequate for replacement of high-dose moxifloxacin in treatment of multi …
BACKGROUND: Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown. ...CONCL …
Levofloxacin Versus Ceftriaxone for the Treatment of Acute Pyelonephritis in Iranian Adults.
Tehrani S, Elyasi F, Abolghasemi S. Tehrani S, et al. Infect Disord Drug Targets. 2021;21(4):603-607. doi: 10.2174/1871526520999200727154214. Infect Disord Drug Targets. 2021. PMID: 32720608 Clinical Trial.
Clinical and microbiological characteristics were compared among patients treated with ceftriaxone and levofloxacin. RESULTS: A total of 59 patients were randomized, 30 to the ceftriaxone group and 29 to the levofloxacin group. The clinical response was that 68.0% o …
Clinical and microbiological characteristics were compared among patients treated with ceftriaxone and levofloxacin. RESULTS: A total …
Levofloxacin in veterinary medicine: a literature review.
Sitovs A, Sartini I, Giorgi M. Sitovs A, et al. Res Vet Sci. 2021 Jul;137:111-126. doi: 10.1016/j.rvsc.2021.04.031. Epub 2021 Apr 30. Res Vet Sci. 2021. PMID: 33964616 Review.
A potent third-generation antimicrobial fluoroquinolone drug, levofloxacin was introduced into human clinical practice in 1993. Levofloxacin is also used in veterinary medicine, however its use is limited: it is completely banned for veterinary use in the EU, and us …
A potent third-generation antimicrobial fluoroquinolone drug, levofloxacin was introduced into human clinical practice in 1993. Le …
Levofloxacin-Induced Hyperpigmentation.
Castellanos-González M, González Morales ML, González-Granda Villalobos J. Castellanos-González M, et al. Actas Dermosifiliogr (Engl Ed). 2019 Oct;110(8):700-701. doi: 10.1016/j.ad.2018.04.010. Epub 2019 May 24. Actas Dermosifiliogr (Engl Ed). 2019. PMID: 31133294 English, Spanish. No abstract available.
A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection.
Li Y, Yin Y, Peng X, Zheng H, Fu F, Liu Z, Wu X, Wu X, Zheng S, Chen N, He L, Ren L, Ni Z, Li D, Liang P, Lv X, Zhang Y. Li Y, et al. Ann Med. 2021 Dec;53(1):217-226. doi: 10.1080/07853890.2020.1861322. Ann Med. 2021. PMID: 33331182 Free PMC article. Clinical Trial.
METHODS: In this randomized, active-controlled clinical trial, the patients with acute uncomplicated UTI were randomized to receive sitafloxacin 100-mg once-daily (qd) or levofloxacin 500-mg qd orally for 3-5 days. The patients with complicated UTI were randomized to recei …
METHODS: In this randomized, active-controlled clinical trial, the patients with acute uncomplicated UTI were randomized to receive sitaflox …
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.
Yuan J, Mo B, Ma Z, Lv Y, Cheng SL, Yang Y, Tong Z, Wu R, Sun S, Cao Z, Wu J, Zhu D, Chang L, Zhang Y; Investigator Group of the Phase 3 Study on Oral Nemonoxacin. Yuan J, et al. J Microbiol Immunol Infect. 2019 Feb;52(1):35-44. doi: 10.1016/j.jmii.2017.07.011. Epub 2017 Aug 2. J Microbiol Immunol Infect. 2019. PMID: 30181096 Free article. Clinical Trial.
The purpose of this study was to assess the efficacy and safety of nemonoxacin compared with levofloxacin in patients with CAP. METHODS: A phase 3, multicenter, randomized (2:1) controlled trial was conducted in adult CAP patients receiving nemonoxacin 500 mg or levoflo …
The purpose of this study was to assess the efficacy and safety of nemonoxacin compared with levofloxacin in patients with CAP. METHO …
10,013 results
You have reached the last available page of results. Please see the User Guide for more information.